Diseases or illnesses affecting the lungs cause the flow of air and blood into and out of your lungs to become impaired. Obstruction in the airflow impairs the lower airways from clearing out mucus which in turn creates an ideal environment for infection. Inflammation in the airways occurs and makes matters worse for the lungs. Inflammation with COPD damages the system responsible for the clearing of mucus in the airways. The risk of developing pneumonia for those with COPD is greater due to already weakened lungs and the inability to filter bacteria and viruses. If treatment for pneumonia is prolonged, it can lead to physical changes within the lungs causing the exchange of oxygen to be greatly diminished and results in respiratory failure.
A case is presented at the hospital of a 2-month-old child, diagnosed with down syndrome, and currently recovering from a case of bronchiolitis. The child, Elisa, is also diagnosed with Tetralogy of Fallot, and she will undergo surgery to correct this defect once she has had time to recover from her bronchiolitis. Elisa is the sixth child or Maria and Hector. She has three brothers and two sisters who range in age from 10 to 25 years old.
Asthma is the swelling that causes you to wheeze making you feel as you can’t breathe it can be treated by epinephrine. Pneumonia is an infection of the lungs caused by bacteria and sometimes it can be treated without treatment. Bronchitis is an infection in the mucus membrane, wheezing and chest pains are some symptoms and it can be treated by prescribing brunch dilator or antibiotics. Sinusitis pressure in the sinuses also nasal discharge treatments are antibiotics and many others. Tonsillitis symptoms include fever, hard for you to swallow and sore throats.
The exudative phase unfolds over the first 1 to 7 days after attack of lung injury. Accumulation in the alveoli of excessive fluid, protein and inflammatory cells that have move into the air spaces from the alveolar capillaries. Intrapulmonary shunt develop and blood passing cannot be oxygenated. Alveolar type I and type II cells are spoiled causing surfactant dysfunction. Alveoli become unstable and collapse and fibrotic changes take place.
In March 2010 President Obama signed into law the Patient Protection and Affordable Care Act (PPACA). The goal was to make health care more affordable, accessible and improve quality, for seniors, families and businesses. One component of the PPACA is the Hospital Readmission Reduction Program (HRRP). The objective of HRRP is to reduce hospital readmissions for selected disease categories where Centers for Medicare and Medicaid Services (CMS) data shows there is considerable room for improvement. This program creates financial incentives for hospitals to reduce cost, implement quality improvement programs and focus on reducing readmissions, within 30 days of discharge, for people admitted with a diagnosis of acute myocardial infarction, heart failure and pneumonia.
Cystic Fibrosis Cystic Fibrosis is a genetic disease that affects the lungs and the digestive system. Because this disease limits breathing ability, it is a life-threatening disease. In the United States alone, 30,000 people have cystic fibrosis and 1,000 new cases of CF are diagnosed every year. Over half the of the people with CF are over the age of 18. (About Cystic Fibrosis)
Research Topic: Chronic Obstructive Pulmonary Disease (COPD) and stigma Research Question: How do individuals with chronic obstructive pulmonary disease (COPD) perceive and experience dealing with COPD service providers? The research question suggests the ontological position that perceptions and experiences of individuals with COPD are meaningful within the social context (Mason, 2012). The epistemological approach will generate data qualitatively, by asking questions, listening, and obtaining information through individuals ' narratives about COPD and service providers (Mason, 2012). The topics covered are knowledge and practices about self-managing COPD, experiences and perceptions about COPD service providers, and barriers to accessing programs.
In the later stages of COPD, oxygen therapy is used to treat the symptoms of COPD. If you cannot get enough air into your lungs, you might not have enough oxygen in your blood. Your doctor can prescribe a device that can push air into your lungs. Your doctor may recommend a portable oxygen tank if your need to oxygen therapy for an extended amount of
Cystic Fibrosis is a serious genetic disorder that affects the insides of a human body. Cystic Fibrosis is a genetic condition in which the lungs and the insides of the human body become clogged with thick sticky mucus. The mucus builds up inside of the body and affects the insides like the lungs, liver , pancreas, your sinuses, and more. Cystic Fibrosis also affects the digestive system which makes food harder and a longer time to digest. Some symptoms for cystic fibrosis are salty-tasting skin(sweat), poor growth, and poor weight gain despite normal food intake.
Because they also encourage mucous secretions, macrophage activity on pneumococci is decreased while bacterial adhesion to the epithelium is increased. Pneumonia is a condition that aggravates the air sacs in one or both lungs. The air sacs may fill with fluid or pus causing cough with phlegm or pus, fever, chills, and difficulty breathing. Cyanosis occurs as a result of the decrease in gas exchange through the inflamed alveolar membrane and subsequent decline in hemoglobin saturation. One of the most common complications of the flu is a bacterial infection.
• Lung disease is usually manifested as obstructive lung disease due to bronchiectasis. Patients often develop difficulty breathing, cough, and wheezing. • Pancreatic disease manifests as recurrent pancreatitis, abdominal pain, diabetes, and malabsorption of nutrients. • Cystic fibrosis if often identified during newborn screening programs in the United States. Some cases are missed and present during older age.
The risk of death from pneumonia will be higher for people with heart disease, diabetes and weakened immune
As a result, these patients can’t bring the carbon dioxide out, they become retain the carbon dioxide which makes it so hard for them to breathe
Many people were given a death sentence, because of the wearing away of their lungs, and I could never imagine going through life with a death sentence. One story that was told was by Les, who had gone to the doctor because of his excessive coughing and they told him he only had 5-10 years to live. He had been amazed by this thought of a death sentence and thought he would never be in this situation. In his own words this is what he said, “What did I get myself into?”. Many of these individuals were asking the same question as Les.
Pneumonia and asthma are two kinds of diseases that affect the airways in the lungs. Although both of them are different, they have some common denominators in the cause, symptoms, and the possibility of treating the inflammation at home. Both pneumonia and asthma make the air sacs in the lungs become tighten or blocked by an inflammation. For example, a person can obtain pneumonia or make asthma become worse after getting any upper respiratory infection such as flu or cold. Some symptoms of pneumonia and asthma are similar to each other such as chest pain, coughing, wheezing, and difficulty in breathing.
Most patients show marked symptomatic and radiographic improvement 1 month after the start of treatment, and significant improvement in almost all. aspects of lung function. There is an incomplete reversal of clinical, hematological, radiological and physiological changes in TPE after treatment, however. Most patients show improvement after a standard 3 weeks of DEC therapy, but many are left with chronic respiratory tract inflammation and a mild form of interstitial lung disease. Relapses occur in 20% of patients followed-up for 5 years.